Genenta Science Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Quarter	H2 2025	H1 2025	H2 2024	H1 2024	H2 2023	H1 2023	H2 2022	H1 2022	H2 2021	H1 2021	H2 2020	H2 2019
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Jun '22 Jun 30, 2022	Dec '21 Dec 31, 2021	Jun '21 Jun 30, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	5.53	5.18	4.58	6.19	3.69	12.21	29.79	34.67	37.24	10.55	15.47	20.14
Short-Term Investments	22.62	12.49	8.08	10.72	15.08	10	-	-	-	-	-	-
Cash & Short-Term Investments	28.15	17.67	12.66	16.91	18.78	22.21	29.79	34.67	37.24	10.55	15.47	20.14
Cash Growth (YoY)	122.35%	4.51%	-32.57%	-23.89%	-36.98%	-35.94%	-19.99%	228.51%	140.80%	-47.60%	-	-
Other Current Assets	1.83	3.33	1.81	1.66	2.48	2.3	1.93	2.74	1.52	1.55	1.07	0.46
Total Current Assets	29.98	21	14.47	18.57	21.26	24.52	31.72	37.41	38.76	12.1	16.53	20.6
Net Property, Plant & Equipment	0.02	0.04	0.04	0.06	0.08	0.1	0.11	0.07	0.02	0.02	0.02	-
Other Long-Term Assets	1.89	0.52	0.31	0.39	1.01	2.11	1.6	0.8	1.24	1.17	0.95	0.75
Total Assets	31.89	21.55	14.82	19.02	22.35	26.73	33.44	38.28	40.03	13.29	17.5	21.35
Accounts Payable	1.81	1	0.5	0.6	0.47	0.48	1.19	0.53	0.19	0.36	0.56	0.57
Accrued Expenses	0.19	0.34	1.26	0.96	1.01	1.08	0.69	0.56	0.84	1.23	1.73	1.87
Other Current Liabilities	0.12	0.25	0.34	0.44	0.26	0.21	0.3	0.12	0.1	0.08	0.05	0.05
Total Current Liabilities	2.12	1.59	2.1	2	1.74	1.77	2.18	1.2	1.14	1.67	2.33	2.49
Long-Term Debt	7.6	7.56	-	-	-	-	-	-	-	-	-	-
Other Long-Term Liabilities	0.33	0.29	0.23	0.2	0.18	0.15	0.12	0.09	0.03	0.02	0.02	0.01
Total Long-Term Liabilities	7.93	7.85	0.23	0.2	0.18	0.15	0.12	0.09	0.03	0.02	0.02	0.01
Total Liabilities	10.05	9.44	2.33	2.2	1.91	1.92	2.3	1.29	1.17	1.69	2.35	2.5
Common Stock	84.26	71.86	68.46	67.85	67.34	67.02	66.6	66.12	65.88	37.14	0.04	0.04
Additional Paid-in Capital	-	-	-	-	-	-	-	-	-	-	36.6	34.71
Accumulated Other Comprehensive Income	0.17	0.13	0.09	0.15	0.23	-	-	-	-	-	-	-
Retained Earnings	-62.59	-59.88	-56.06	-51.18	-47.14	-42.22	-35.47	-29.13	-27.02	-	-21.49	-15.9
Shareholders' Equity	21.84	12.11	12.5	16.82	20.43	24.8	31.14	36.99	38.86	11.6	15.15	18.85
Total Liabilities & Equity	31.89	21.55	14.82	19.02	22.35	26.73	33.44	38.28	40.03	13.29	17.5	21.35

SEC Filings: 10-K · 10-Q